Régulation des pratiques organisationnelles de fraude médicamenteuse via les "mondes pharmaceutiques": une analyse comparative entre les modèles suisse et français

Rufin Nzalakanda
Additional contact information
Rufin Nzalakanda: LIRSA - Laboratoire interdisciplinaire de recherche en sciences de l'action - CNAM - Conservatoire National des Arts et Métiers [CNAM]

Post-Print from HAL

Date: 2018-04
References: Add references at CitEc
Citations:

Published in François Garçon, Sonny Perseil, Yvon Pesqueux. La Suisse est-elle un modèle ?, L'Harmattan, pp. 187-215, 2018, 978-2-343-14621-8

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03100962

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().